The above chart presents the market trend analysis for akmed pharma pvt ltd.tl 23.03.2015 inv 14lk0601akm from 2022 to 2023.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2023, the company has completed 2 transactions, with a transaction quantity of 2063.69 and a transaction weight of 2063.69.
akmed pharma pvt ltd.tl 23.03.2015 inv 14lk0601akm is sri lanka Buyer,
and primarily engages in the import and export business of products such as oral solution,prednisolone,pharmaceutical product.
According to the 52wmb.com global trade database, as of 2023-05-09, the company has completed 33 international trades,
with its main trading regions covering costa rica,philippines,japan etc.
The core products include HS30043900,HS30061000,HS90189000 etc,
and its main trading partners are lloyd laboratories inc.,zuiko medical corp.,lloyed laboratories inc..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on akmed pharma pvt ltd.tl 23.03.2015 inv 14lk0601akm is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.